Ñòàæ: 25
Âðà÷ âûñøåé êàòåãîðèè
Àêóøåð, Ãèíåêîëîã, Àêóøåð-ãèíåêîëîã
Ïðèåì îò 5500 4950 - 10%

Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:

Ñòîèìîñòü ïðè¸ìà â «ÝìáðèËàéô»
Ñïàññêèé ïåð. ä. 14/35 (âõîä ñ Ñàäîâîé óëèöû, ä.35)
 Ñåííàÿ ïëîùàäü  Ãîñòèíûé äâîð  Ñïàññêàÿ  Àäìèðàëòåéñêàÿ  Ñàäîâàÿ
Ñòîèìîñòü ïðè¸ìà â «NuAnce (Íþàíñ)»
Ñïîðòèâíàÿ ä. 2
 Êðåñòîâñêèé îñòðîâ  ×êàëîâñêàÿ
Íà êàðòå

Îáùèå ñâåäåíèÿ

Ñïåöèàëèçèðóåòñÿ íà ëå÷åíèè ãèíåêîëîãè÷åñêèõ ïðîáëåì:
  • âîñïàëèòåëüíûõ çàáîëåâàíèé îðãàíîâ ìàëîãî òàçà;
  • âîñïàëèòåëüíûõ çàáîëåâàíèé íàðóæíûõ ïîëîâûõ îðãàíîâ;
  • ïàòîëîãèé øåéêè ìàòêè;
  • áåñïëîäèÿ;
  • ìîëî÷íèöû;
  • êèñòû â ìàëîì òàçó;
  • äèñôóíêöèé ÿè÷íèêîâ ìèîìû ìàòêè.

Îáðàçîâàíèå

  • Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî", Òþìåíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (1998 ã.)
  • Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Àêóøåðñòâî è ãèíåêîëîãèÿ", Ñåâåðî-Çàïàäíûé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. È.È.Ìå÷íèêîâà (2001 ã.)
  • Àñïèðàíòóðà ïî ñïåöèàëüíîñòè "Àêóøåðñòâî è ãèíåêîëîãèÿ ", Ñåâåðî-Çàïàäíûé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. È.È.Ìå÷íèêîâà (2009 ã.)

Ïîâûøåíèå êâàëèôèêàöèè

  • "Àêóøåðñòâî è ãèíåêîëîãèÿ", Ñåâåðî-Çàïàäíûé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èì. È.È. Ìå÷íèêîâà (2005 ã.)
  • "Ìåíåäæìåíò îðãàíèçàöèé (ìåíåäæìåíò, ìåæäóíàðîäíûé ìåíåäæìåíò, êîíòðîëëèíã, óïðàâëåíèå ïåðñîíàëîì, êîó÷èíã)", Ãåðìàíèÿ (2006 ã.)
  • "Îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ è îáùåñòâåííîå çäîðîâüå", Òþìåíñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò (2007 ã.)
  • "Ìåíåäæìåíò â çäðàâîîõðàíåíèè" (2007 ã.)
  • "CICE Centre International de Chirurgie endoscopigue" (2012 ã.)
  • "Óëüòðàçâóêîâàÿ äèàãíîñòèêà", Ñàíêò-Ïåòåðáóðãñêèé ãîñóäàðñòâåííûé óíèâåðñèòåò (2014 ã.)
  • "Àêóøåðñòâî è ãèíåêîëîãèÿ" (2014 ã.)
  • "Êîëüïîñêîïèÿ" (2014 ã.)
  • "Êîððåêöèÿ èíâîëþöèîííûõ èçìåíåíèé àíîãåíèòàëüíîé îáëàñòè ïðåïàðàòàìè ãèàëóðîíîâîé êèñëîòû ó æåíùèí" (2015 ã.)
  • "Ñèíòåòè÷åñêèå ñëèíãè â êîððåêöèè ñòðåññîâîãî íåäåðæàíèÿ ìî÷è ó æåíùèí" (2016 ã.)
  • "Ðåêîíñòðóêòèâíî- ïëàñòè÷åñêàÿ õèðóðãèÿ ïðè ìèîìå ìàòêè" (2016 ã.)
  • "Âàãèíàëüíûé äîñòóï â êîððåêöèè ïðîëàïñà òàçîâûõ îðãàíîâ" (2016 ã.)
  • "Ëàïàðîñêîïè÷åñêàÿ ãèñòåðýêòîìèÿ" (2016 ã.)
  • "Èíòèìíûé ôèëëèíã â ãèíåêîëîãèè" (2016 ã.)
  • "Õèðóðãèÿ èíôèëüòðàòèâíîãî ýíäîìåòðèîçà" (2016 ã.)
  • "Äîñòèæåíèÿ â èçó÷åíèè è ëå÷åíèè ìèîìû ìàòêè" (2016 ã.)
  • "Æåíñêèå ïðîáëåìû ìåãàïîëèñà: äèôôåðåíöèðîâàííûé ïîäõîä ê âûáîðó ãîðìîíàëüíîé êîíòðàöåïöèè" (2016 ã.)
  • "Äèñêóññèîííûå âîïðîñû ñîâðåìåííîãî àêóøåðñòâà" (2016 ã.)
  • "Äåñòðóêòèâíûå ìåòîäû ëå÷åíèÿ çàáîëåâàíèé øåéêè ìàòêè" (2016 ã.)
  • "Ãèñòåðîðåçåêòîñêîïèÿ" (2016 ã.)
  • "Îôèñíàÿ ãèñòåðîñêîïèÿ" (2016 ã.)
  • "Àêòóàëüíûå ïðîáëåìû ãèíåêîëîãè÷åñêîé ýíäîêðèíîëîãèè" (2016 ã.)
  • "Çäîðîâüå æåíùèíû 40+. Êîìïëåêñíûé ïîäõîä â anti-age òåðàïèè" (2016 ã.)
  • "Ãèñòåðîñêîïèÿ. Âíóòðèìàòî÷íàÿ õèðóðãèÿ" (2016 ã.)
  • "Àêòóàëüíûå âîïðîñû ïàòîëîãèè ìîëî÷íîé æåëåçû" (2017 ã.)
  • "Èçáðàííûå âîïðîñû îïåðàòèâíîé ãèíåêîëîãèè è ãèñòåðîñêîïèè" (2017 ã.)
  • "Ìàñòîïàòèÿ è ïðîôèëàêòèêà ðàêà ìîëî÷íîé æåëåçû" (2017 ã.)
  • "Plasmoliftig ÒÌ â ãèíåêîëîãèè" (2017 ã.)
  • "Êóðñ ðåãåíåðàòèâíîé ìåäèöèíû íà îñíîâå àóòîëîãè÷íîé ïëàçìû â ãèíåêîëîãèè. Òåõíîëîãèÿ Ïëàçìîëèôòèíã" (2017 ã.)
  • "Êîëüïîñêîïèÿ ñ îñíîâàìè êîëüïîöèòîëîãèè" (2018 ã.)
  • "Àêòóàëüíûå âîïðîñû ôèçèîòåðàïèè (ïðèðîäîëå÷åíèÿ) â àêóøåðñòâå è ãèíåêîëîãèè" (2018 ã.)
  • "Ýñòåòè÷åñêàÿ è ðåêîíñòðóêòèâíàÿ óðîãèíåêîëîãèÿ" (2018 ã.)
  • "Ïðèìåíåíèå èíúåêöèîííûõ ìåòîäèê àíîãåíèòàëüíîé îáëàñòè ïðåïàðàòàìè - Amalain, Reneall, Revi" (2018 ã.)
  • "Äåñòðóêòèâíûå ìåòîäû ëå÷åíèÿ çàáîëåâàíèé øåéêè ìàòêè" (2019 ã.)
  • "Èíúåêöèîííûå òåõíîëîãèè äëÿ êîððåêöèè èíâîëþöèîííûõ èçìåíåíèé àíîãåíèòàëüíîé îáëàñòè ó æåíùèí" (2019 ã.)

Ìåñòà ðàáîòû

  • Ðóêîâîäèòåëü Öåíòðà ýñòåòè÷åñêîé è ðåêîíñòðóêòèâíîé óðîãèíåêîëîãèè, Ôåäåðàëüíûé èíñòèòóò ïåäàãîãè÷åñêèõ èçìåðåíèé, ãîðîä Ñàíêò- Ïåòåðáóðã Äîöåíò, Êàôåäðà Àêóøåðñòâà è ãèíåêîëîãèè èì. Ñ.Í. Äàâûäîâà ÑÇÃÌÓ èì. È.È.Ìå÷íèêîâà, ãîðîä Ñàíêò- Ïåòåðáóðã Âðà÷-àêóøåð-ãèíåêîëîã âûñøåé êàòåãîðèè, êàíäèäàò ìåäèöèíñêèõ íàóê, Êëèíèêà êîñìåòîëîãèè NuAnce, ãîðîä Ñàíêò-Ïåòåðáóðã Ñåðòèôèöèðîâàííûé òðåíåð Plasmoliftig TM, ãîðîä Ñàíêò- Ïåòåðáóðã Âðà÷-àêóøåð-ãèíåêîëîã, Embrylife, ãîðîä Ñàíêò-Ïåòåðáóðã (2024 ã.)

íàïèñàëà
î âðà÷å, â êëèíèêå:
Ñàíêò-Ïåòåðáóðã, Ñïîðòèâíàÿ ä. 2

Ïðèåì ïðîø¸ë î÷åíü õîðîøî, ÿ âñåì îñòàëàñü äîâîëüíà. Äîêòîð äàëà ìíå ñîâåòû, ñêàçàëà êàê äàëüøå áûòü è íàçíà÷èëà ëå÷åíèå. Ìàêà Èíâåðèåâíà, ÿ áû ñêàçàëà, ãðàìîòíàÿ âðà÷.

âðà÷:
îòíîøåíèå:
êâàëèôèêàöèÿ:
öåíà-êà÷åñòâî:

Îòâåò îò NuAnce (Íþàíñ) íà Ñïîðòèâíîé äëÿ ïîñåòèòåëÿ Ìàðèÿ

Äîáðûé äåíü, Ìàðèÿ! Áëàãîäàðèì çà îòçûâ. Áóäåì ðàäû âèäåòü Âàñ ñíîâà!

Ñïåöèàëèçàöèÿ Âðà÷à

Ïîìîæåì íàéòè âðà÷à

Îñòàâüòå ñâîé íîìåð è ìû âàì ïåðåçâîíèì â òå÷åíèå 10 ìèíóò

Âû äåéñòâèòåëüíî õîòèòå
îòìåíèòü çàïèñü?

Åñëè ó âàñ âîçíèêëè âîïðîñû,
çàäàéòå èõ íàì ïî òåëåôîíó åäèíîé ñëóæáû çàïèñè
+7 (812) 416-06-18
èëè èñïîëüçóéòå